The effect of comorbidities of preeclampsia and eclampsia on maternal and fetal outcome


  • Abinaya M. C. Assam Medical college and Hospital, Dibrugarh, Assam, India
  • Milon K. Taye Assam Medical college and Hospital, Dibrugarh, Assam, India
  • Nabajyoti Saikia Assam Medical college and Hospital, Dibrugarh, Assam, India
  • Long Teron Assam Medical college and Hospital, Dibrugarh, Assam, India
  • Pulak Kalita Assam Medical college and Hospital, Dibrugarh, Assam, India



Eclampsia, Preeclampsia, Comorbidities, Maternal and fetal outcome


Background: The aim of this study is to comparatively assess the maternal and fetal outcome in preeclampsia and eclampsia patients with and without comorbidities. The objectives are to assess the comorbidities associated with preeclampsia and eclampsia cases and to find out the effects of the comorbidities of preeclampsia and eclampsia on maternal and fetal outcome.

Methods:380 patients who had attended antenatal OPD and emergency labour room of Assam medical college and hospital, Dibrugarh during June 2020 to July 2021 with preeclampsia and eclampsia were selected for present study. Based on relevant history, clinical and laboratory findings, these patients were further evaluated for associated comorbidities. The cases were distributed in the respective comorbidity group. Then the outcome of the mother and the baby were analyzed till the day of discharge in patients without comorbidities and with comorbidities and the same was compared.

Results: The eventful maternal (44.1%) and fetal (50.92%) outcome was more in preeclampsia and eclampsia patients with comorbidities than in patients without comorbidities which is statistically significant, (p value=0.029), (p value=0.009) respectively.

Conclusions: The effect of preeclampsia and eclampsia itself would adversely affect the pregnancy outcome and the effect is worse when associated with comorbidities. Appropriate prenatal counselling and optimization of the comorbidities is critical for women who are planning pregnancy.


Cunningham FG. Hypertensive disorders. In: Williams Obstetrics. 25th ed. 2018;1566-667.

Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based study. BMC Preg Child. 2021;21(1):1-9.

Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-74.

Lockwood CJ. ACOG task force on hypertension in pregnancy. Contemp Obstet Gynecol. 2013;58(12):10.

Li AA, Rayis DA, Abdallah TM, Elbashir MI, Adam I. Severe anaemia is associated with a higher risk for preeclampsia and poor perinatal outcomes in Kassala hospital, eastern Sudan. BMC Res. 2011;4(1):311.

Banik P, Devi RP, Bidya A, Tamphasana A, Agalya M, Singh LR. Thyroid dysfunction in preeclampsia and related fetomaternal outcomes. Int J Reprod Contracept Obstet Gynecol 2009;8(5):1929.

Deshpande S, Yelikar K, Patil S, Andurkar S. Maternal thyroid hormone status in preeclampsia: a tertiary care hospital-based study. Int J Reprod Contracept Obstet Gynecol. 2015;4(6):1853-7.

Ganesh KS, Unnikrishnan B, Nagaraj K, Jayaram S. Determinants of pre-eclampsia: a case–control study in a district hospital in South India. Indian J Commu Med. 2019;23:32-9.

Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.

Czerwinski S, Gollero J, Qiu C, Sorensen TK, Williams MA. Migraine-asthma comorbidity and risk of hypertensive disorders of pregnancy. J Preg. 2012;2012:858097.

Agun E, DeFilippis EM, Noble S, LaSala A, Waksmonski C, D’Alton ME, et al. Cardiovascular care for pregnant women with cardiovascular disease. J Am Coll Cardiol. 2020;76(18):2102-13.

Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol. 2000;95(4):487-90.

Leaños-Miranda A, Campos-Galicia I, Berumen-Lechuga MG, Molina-Pérez CJ, García-Paleta Y, Isordia-Salas I, Ramírez-Valenzuela KL. Circulating angiogenic factors and the risk of preeclampsia in systemic lupus erythematosus pregnancies. J Rheumetol. 2010;23:43-9.

Ahmed MA, Sharif ME, Rayis DA, Nasr AM, Adam I. Hepatitis B infection and preeclampsia among pregnant Sudanese women. Virol J. 2018;15(1):1-4.

Madhuri C, Varalakshmi Y. Retrospective study on fetomaternal outcome is gestational hypertension, pre eclampsia and eclampsia in a tertiary care centre. Indian J Basic Applied Med Res. 2019;8:246-55.

Igberase GO, Ebeigbe PN. Eclampsia: ten-years of experience in a rural tertiary hospital in the Niger delta, Nigeria. J Obstet Gynecol. 2006;26(5):414-7.

Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe preeclampsia related to pre-existing conditions. Int J Epidemol. 2007;36(2):412-9.






Original Research Articles